Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: DALTS who wrote (9592)	7/1/1998 2:25:00 PM
From: Scott H. Davis	Respond to of 14328

Actually the upside/downside risk is pretty good here, IF your perspective is over a year out before selling. Timing is a big issue with biotechs. Get in too soon, and its dead money unless you're a good enough trader to play swings - accumulating & profit taking in the process. But if you're a buy & hold investor, timing may not be too good. Short term, timing may be good - TRIBY is somewhat oversold and at some support at 1 7/8 - just be prepared to sell when it approaches upper bolinger bands unless you plan to hold LONG. But overall, the trend is bad and money flow is putrid. ISIP, VICL, & LGND had a lot of promise 2 years ago too & have made good progress. But in the process of development there are a lot of frustrated buy & hold nvestors who got in to early. FYI Scott